Currently, Wegovy is FDA approved for the following: Children ages 12 years or older with a body mass index (BMI) at or above the 95th percentile for their sex and age Adults with a BMI at or above 30 Adults with a BMI at or above 27 and at least one weight-related health condition, such as heart disease, diabetes, high blood pressure, or sleep apnea Adults with a BMI at or above 27 with established cardiovascular disease and a risk of major adverse cardiovascular events (like heart attack or stroke) Adults with noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis Note that there are slightly different prescribing rules for Wegovy pills versus Wegovy injections
Well guide you on the best follow-up treatments to keep you feeling your best
Freites-Martinez A, Santana N, Arias-Santiago S, Viera A
It offers deeper diagnostics than any competitor, a broader treatment menu spanning TRT, peptides, and GLP-1 medications, and concierge-level health coaching that reviews 60 to 100+ biomarkers per panel
Overview of Glucagon-like Peptide-1 (glp-1) Receptor Agonists As research continues, the potential applications of Semaglutide may extend beyond weight management, sparking interest in its effects on metabolic disorders, cardiovascular health, and even type 2 diabetes
Some patients respond to lower doses, while others need the maximum dose to see results